Pelagia Vorgia

Pelagia Vorgia

Auto-generated profile, based on publicly available information

Pelagia Vorgia

Institute of Agri-food and Life Sciences, Hellenic Mediterranean University, Heraklion, Greece

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 November 2024 in Biomedical Signal Processing and Control
Verified
Journal Article
Closed access
AKApostolos Karasmanoglou
Apostolos Karasmanoglou
Giorgos GiannakakisGiorgos Giannakakis
Giorgos Giannakakis
PVPelagia Vorgia
Pelagia Vorgia
MAMarios Antonakakis
Marios Antonakakis
MZMichalis Zervakis
Michalis Zervakis

29 September 2022 in Neurological Sciences
Verified
Journal Article
Open access
PDF file
CKChristina Kamari
Christina Kamari
EGEmmanouil Galanakis
Emmanouil Galanakis
MRMaria Raissaki
Maria Raissaki
GBGeorge Briassoulis
George Briassoulis
GVGeorgia Vlachaki
Georgia Vlachaki
PVPelagia Vorgia
Pelagia Vorgia
Background: Multiple sclerosis (MS) is a demyelinating disease of the central nervous system, rare during childhood. MS variations, like tumefactive MS and Balo concentric sclerosis, constitute puzzling to treat diagnostic dilemmas for pediatric patients. Differential diagnosis, mainly from brain tumors, is an absolute necessity. In addition, apart from treating acute attacks, immunomodulatory alternatives are limited. Case: We present a 12.5-year-old boy diagnosed, 5 years ago, with tumefactive relapsing–remitting MS, with severe recurrent clinical attacks. Definite diagnosis of demyelination was achieved via combined brain imaging including magnetic resonance (MR) imaging, MR spectroscopy and computed tomography, avoiding brain biopsy. Acute attacks showed satisfactory response to aggressive treatment choices, like plasmapheresis and cyclophosphamide, but age-appropriate immunomodulating treatment was available, only 2 years later. Finally, after a last radiological relapse, when he was 10 years old, fingolimod was initiated. He has been clinically and radiologically stable since, presenting an excellent treatment tolerance.

15 October 2025 in European Journal of Paediatric Neurology
Verified
Journal Article
Closed access
MSMaria Spanou
Maria Spanou
Vasileios C. SkoutelisVasileios C. Skoutelis
Vasileios C. Skoutelis
ZDZacharias Dimitriadis
Zacharias Dimitriadis
EKEleftheria Kokkinou
Eleftheria Kokkinou
KKKonstantina Kosma
Konstantina Kosma
ADArgirios Dinopoulos
Argirios Dinopoulos

17 November 2022 in Neurological Sciences
Verified
Journal Article
Open access
PDF file
CKChristina Kamari
Christina Kamari
EGEmmanouil Galanakis
Emmanouil Galanakis
MRMaria Raissaki
Maria Raissaki
GBGeorge Briassoulis
George Briassoulis
GVGeorgia Vlachaki
Georgia Vlachaki
PVPelagia Vorgia
Pelagia Vorgia